Ardelyx (ARDX) vs Obsidian Therapeutics (OBX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Ardelyx is the larger company by market cap ($844.3 million vs $756.1 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ARDX | OBX |
|---|---|---|
| Share price | $3.27 | $12.24 |
| Market cap | $844.27M | $756.10M |
| 1-day change | +0.31% | -7.27% |
| YTD return | -43.91% | — |
| 1-year return | -35.38% | — |
| 5-year return | +202.78% | — |
| Forward P/E | 11.26 | — |
| EPS (TTM) | $-0.23 | $-1.63 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $8.40 | $49.97 |
| 52-week low | $3.18 | $12.07 |
| Distance from 52-week high | -61.07% | -75.51% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +294.50% | +218.63% |
| Average volume | 4.10M | 367.35K |
| Shares outstanding | 258.19M | 61.77M |
| Employees | 489 | 87 |
| Sector | Healthcare | Health Care |
| Industry | Biotechnology | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- The two companies sit in different sectors: Ardelyx in Healthcare and Obsidian Therapeutics in Health Care.
About Ardelyx
ARDX stock →Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.
Healthcare · Biotechnology · 489 employees
About Obsidian Therapeutics
OBX stock →Obsidian Therapeutics, Inc. operates as a clinical-stage biotechnology company developing engineered cell and gene therapies.
Health Care · Biotechnology: Pharmaceutical Preparations · 87 employees
ARDX vs OBX FAQ
Which is bigger, Ardelyx or Obsidian Therapeutics?
Ardelyx (ARDX) is larger, with a market capitalization of $844.27M compared with $756.10M for Obsidian Therapeutics (OBX).
Are Ardelyx and Obsidian Therapeutics in the same industry?
No. Ardelyx is in the Healthcare sector, while Obsidian Therapeutics is in Health Care.